Quantum Biosystems Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Quantum Biosystems General Information

Description

Developer of quantum mechanics systems designed to provide assistance in the development of innovative single-molecule DNA sequencers. The company's systems offer a sequencing system that gathers genetic data with broad applicability through accelerated use of DNA and RNA sequencing, enabling clients to unlock genetically modified codes with physics, thereby promoting development in their research.

Contact Information

Website
www.quantumbiosystems.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 5-8-3 Nishinakajima, Yodogawa-ku
  • Shin-Osaka Sun R North Building, Room 601
  • Osaka, 532-0001
  • Japan
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Nanotechnology, Life Sciences
Corporate Office
  • 5-8-3 Nishinakajima, Yodogawa-ku
  • Shin-Osaka Sun R North Building, Room 601
  • Osaka, 532-0001
  • Japan

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quantum Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 10-Jan-2022 Completed Out of Business
7. Later Stage VC (Series C2) 30-Nov-2018 Completed Generating Revenue
6. Accelerator/Incubator 11-Jun-2018 Completed Generating Revenue
5. Later Stage VC (Series C) 09-Feb-2015 Completed Generating Revenue
4. Grant 17-Dec-2014 Completed Generating Revenue
3. Early Stage VC (Series B) 19-Feb-2014 Completed Generating Revenue
2. Early Stage VC (Series A) 29-Apr-2013 $1.33M $1.33M Completed Startup
1. University Spin-Out 07-Jan-2013 Completed Startup
To view Quantum Biosystems’s complete valuation and funding history, request access »

Quantum Biosystems Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Class C2 Preferred
Series C
Series B 1,500,000 $2.65 $2.65 1x $2.65 12.88%
Series A 1,300,000 $0.88 $0.88 1x $0.88 11.17%
To view Quantum Biosystems’s complete cap table history, request access »

Quantum Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of quantum mechanics systems designed to provide assistance in the development of innovative single-molecule D
Biotechnology
Osaka, Japan

Baltimore, MD
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quantum Biosystems Competitors (36)

One of Quantum Biosystems’s 36 competitors is Personal Genome Diagnostics, a Formerly VC-backed company based in Baltimore, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD
GnuBIO Formerly VC-backed Cambridge, MA
Diagenode Formerly VC-backed Seraing, Belgium
Cellecta Private Debt Financed Mountain View, CA
Bionano Genomics Formerly VC-backed San Diego, CA
You’re viewing 5 of 36 competitors. Get the full list »

Quantum Biosystems Patents

  • 59

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Quantum Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210238672-A1 Systems and methods for detection of biomolecules Inactive 18-Dec-2019
JP-2019022522-A Method and apparatus for controlling moving speed of substance and utilization thereof Inactive 25-Oct-2018
JP-2018151397-A Single molecule recognition method, device, and program Inactive 01-May-2018
EP-3688449-A1 Nanoelectrode devices and methods of fabrication thereof Inactive 27-Sep-2017
EP-3688449-A4 Nanoelectrode devices and methods of fabrication thereof Inactive 27-Sep-2017 G01N27/3276
To view Quantum Biosystems’s complete patent history, request access »

Ready to get started?

Request a free trial

Quantum Biosystems FAQs

  • When was Quantum Biosystems founded?

    Quantum Biosystems was founded in 2013.

  • Where is Quantum Biosystems headquartered?

    Quantum Biosystems is headquartered in Osaka, Japan.

  • What industry is Quantum Biosystems in?

    Quantum Biosystems’s primary industry is Biotechnology.

  • Is Quantum Biosystems a private or public company?

    Quantum Biosystems is a Private company.

  • What is Quantum Biosystems’s current revenue?

    The current revenue for Quantum Biosystems is .

  • How much funding has Quantum Biosystems raised over time?

    Quantum Biosystems has raised $34.9M.

  • Who are Quantum Biosystems’s competitors?

    Personal Genome Diagnostics, GnuBIO, Diagenode, Cellecta, and Bionano Genomics are some of the 36 competitors of Quantum Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »